PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1707421
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1707421
Prescription Hair Loss and Hair Removal Drugs Market, By Drug Type, By Gender, By Application, By Route of Administration, By Geography
Global Prescription Hair Loss and Hair Removal Drugs Market is estimated to be valued at USD 32.24 Bn in 2025 and is expected to reach USD 52.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 32.24 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.10% | 2032 Value Projection: | USD 52.14 Bn |
Prescription hair loss refers to the loss of hair from the scalp or other parts of the body that occurs due to aging, hormonal changes, medical conditions, stress or genetic predisposition. Global prescription hair loss and hair removal drugs market growth is driven primarily by rising geriatric population who are more prone to hair fall issues. Furthermore, easy availability of generic drugs coupled with growing consumer awareness about various treatment options for hair loss can also drive the market growth. However, side effects associated with prolonged usage of these drugs and availability of alternative treatments can pose challenges to industry players.
Market Dynamics:
Global prescription hair loss and hair removal drugs market growth is driven by factors like rising prevalence of alopecia areata, androgenic alopecia and other medical conditions causing hair loss. Growing geriatric population who are at an increased risk of suffering from hair thinning and balding can also drive the market growth. Rising R&D activities leading to new product launches catering to gender-specific hair loss issues plays a crucial role. However, factors such as availability of alternative hair loss treatments including hair transplant surgery, wigs and hair extensions can hamper the market growth. Moreover, side effects associated with long term use of hair loss drugs such as sexual side effects, depression and heart issues can hamper the market growth. Emerging markets in Asia Pacific and Latin America present lucrative opportunities for product penetration.
Key features of the study:
This report provides in-depth analysis of the global prescription hair loss and hair removal drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global prescription hair loss and hair removal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck, Johnson & Johnson, Procter & Gamble, L'Oreal, Unilever, Taisho Pharmaceuticals, Rohto Pharmaceutical, Shiseido, and Lifes2Good
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global prescription hair loss and hair removal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prescription hair loss and hair removal drugs market
Detailed Segmentation-
- By Drug Type Insights (Revenue, USD Bn, 2020 - 2032)
- Hair Loss Medications
- Oral Contraceptive Pills
- Hair Removal Medications
- By Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Chronic Hair Loss
- Acute Hair Loss
- By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Topical
- Oral
- Injectable
- By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- By Regional Insights (Revenue, USD Bn 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- L'Oreal S.A.
- Galderma S.A.
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan N.V.
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Gender
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Prescription Hair Loss and Hair Removal Drugs Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Prescription Hair Loss and Hair Removal Drugs Market, By Drug Type, 2021 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hair Loss Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral Contraceptive Pills
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hair Removal Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Prescription Hair Loss and Hair Removal Drugs Market, By Gender, 2021 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Prescription Hair Loss and Hair Removal Drugs Market, By Application, 2021 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Chronic Hair Loss
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Acute Hair Loss
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Prescription Hair Loss and Hair Removal Drugs Market, By Route of Administration, 2021 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Prescription Hair Loss and Hair Removal Drugs Market, By Distribution Channel, 2021 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Prescription Hair Loss and Hair Removal Drugs Market, By Region, 2021 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Gender Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Johnson & Johnson
- Bausch Health Companies Inc.
- L'Oreal S.A.
- Galderma S.A.
- Revivogen
- Hims, Inc.
- Evolus, Inc.
- Aclaris Therapeutics, Inc.
- Amgen Inc.
- Sientra, Inc.
- Dr. Reddy's Laboratories Ltd.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Mylan N.V.
- Zynerba Pharmaceuticals, Inc.
- Apex Therapeutics, LLC
- Pfizer Inc.
12. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
